Dimensional Fund Advisors LP Geron Corp Transaction History

Dimensional Fund Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$2.03 - $2.42 $2,023 - $2,412	997 Added 0.63%	159,979 $387,000
Q3 2022 Nov 10, 2022	SELL	$1.67 - $2.94 $23,714 - $41,748	-14,200 Reduced 8.2%	158,982 $372,000
Q2 2021 Aug 12, 2021	SELL	$1.25 - $1.83 $16,372 - $23,969	-13,098 Reduced 7.03%	173,182 $244,000
Q1 2021 May 14, 2021	BUY	$1.52 - $2.1 $6,066 - $8,381	3,991 Added 2.19%	186,280 $294,000
Q4 2020 Feb 25, 2021	BUY	$1.55 - $2.05 $282,547 - $373,692	182,289 New	182,289 $290,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.54B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.